MedTrace Logo

End Diagnostic Overshadowing

NCT06608758 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120000

Last updated 2026-08-05

No results posted yet for this study

Summary

The goal of this study is to address the critical issue of diagnostic overshadowing by applying the Collective Impact Model40 to co-produce our End Diagnostic Overshadowing program with academic, health systems, health professional, PWDs, family members, and community stakeholders. Through this work, we will identify and address mechanisms that contribute to diagnostic overshadowing and diagnostic errors among people with disabilities. The main questions to answer are whether knowledge about diagnostic errors and confidence will improve with health care providers and professionals involved in diagnostic provesses, whether developed algorithms to identify patients at risk of diagnpstic error will be used, whether there will be change in time to diagnostic evaluation for PWD from the specified 5 population groups and with the specified diagnoses prone to error, and whether changes in usage of CPT Evaluation and Management codes will occur.

Conditions

  • Disabilities Multiple

Interventions

BEHAVIORAL

Electonic health record prompts with education

1. . A baseline description of patients aged ≥ 3 to 89 years old with one or more of 26 diagnoses prone to error was developed to compare cases of patients with specific disabilities (major mobility impairments, severe mental health concerns, severe visual impairments, severe hearing loss, and IDD) versus cases of patients without the specific disabilities who have these diagnoses. 2. Initial manual chart reviews on PWDs with specific diagnoses of sepsis and metastatic breast cancer with two of the disability groups, patients with intellectual disabilities and/or autism and with severe mental illness were done. 3. We analyzed mammogram usage and factors related to usage among women ≥ 40 years old with IDD and with severe mental health issues 3\) We are working on algorithms to identify providers whose female patients age \> 40 years old to encourage outreach and to identify the patients needing mammograms for outreach. Developing educational materials for both providers and patients.

OTHER

Standard of care

Patients without disabilities will receive standard care related to electronic health record prompts, alerts, and decision supports.

Sponsors & Collaborators

  • St. John Fisher College

    collaborator UNKNOWN

  • University of Minnesota

    collaborator OTHER

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Sarah H Ailey, PhD RN · Rush University College of Nursing

Eligibility

Min Age
3 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-22
Primary Completion
2029-03-31
Completion
2029-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06608758 on ClinicalTrials.gov